GE Healthcare Technologies Inc. received U.S. FDA approval for its novel radiotracer, Flyrcado (flurpiridaz F-18), for use in ...
Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) and keeping ...
Zacks.com on MSN13h
GE HealthCare Stock Likely to Rise After FDA Approval of FlyrcadoGE HealthCare Technologies, Inc. GEHC announced that it has received FDA approval for Flyrcado (flurpiridaz F 18), a ...
GlobalData on MSN15h
GE HealthCare’s Flyrcado PET radiotracer secures FDA approvalFlyrcado is designed for patients with known or suspected CAD, providing a ready-to-use unit dose that can be manufactured ...
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback